Cartesian Gets Phase II Win in Myasthenia Gravis, Looks to Raise $130M in Fin... Biospace, 02 Jul 2024 Pictured: Illustration of CAR-T cells attacking cell/iStock, Nemes Laszlo Cartesian Therapeutics announced Tuesday its lead…